Kanuni Sultan Suleyman Education and Research Hospital
Istanbul, Turkey, Turkey (Türkiye)
NCT Number: NCT06940856
In adults and children low or high blood chloride levels are linked to the risk of death. The aim of this observational study is to determine whether there is a relationship between low or high blood chloride levels and the risk of death or long-term lung problems. We will also learn the risk factors and associated conditions of high or low blood chloride levels. We will include infants born before 32 weeks of pregnancy or have a birth weight of less than 1500 grams in the study. The main question it aims to answer is:
Is there a relationship between low or high blood chloride levels in the first 4-6 weeks of life and risk of death or long-term lung problems in premature babies? We will examine the medical reports of babies who were followed up in neonatal intensive care unit over the past 5 years.
Trial opening soon.
Get Notified1 hour–6 week
All sexes
Observational
Istanbul, Turkey, Turkey (Türkiye)
Chloride balance usually parallels that of sodium, and it is strictly correlated to the extracellular volume balance. In addition plasma chloride and bicarbonate concentrations are inversely regulated through the chloride-bicarbonate exchange pump in renal collecting ducts, independent of sodium. Consequently, plasma chloride levels are closely correlated with pH (hypochloremia/metabolic alkalosis, hyperchloremia/metabolic acidosis).
In adults, dyschloremia is associated with mortality, acute kidney injury, and prolonged hospital stay. Hyperchloremia is often associated with severe sepsis. It has been shown that resuscitation with high-chloride fluids (eg: saline solution) instead of balanced fluids (e.g., Ringer's lactate) increases the need for inotropes in critically ill adults. Similarly, hyperchloremia in septic pediatric patients is linked to acute renal injury requiring dialysis, increased inotropic support, and mortality. In 1979, infants fed with chloride-deficient formula were reported to develop impaired head growth and neurologic sequelae.
Although serum chloride is routinely measured in neonatal intensive care units, its clinical significance is often overlooked. For this reason unlike sodium, literature on chloride metabolism in preterm infants is exceedingly limited.
Advancements in perinatal care over the past 50 years have significantly improved survival rates in preterm infants. However, a large proportion of very preterm infants who survive the neonatal period develop bronchopulmonary dysplasia (BPD). BPD, a chronic lung disease, manifests clinically through persistent respiratory support and/or oxygen dependency. Despite efforts to optimize neonatal care -such as controlled oxygen usage, non-invasive ventilation, volume-guarantee techniques, high-frequency ventilation, and caffeine therapy- BPD remains the most common complication among preterm infants and is associated with increased morbidity and mortality.
It has been suggested that extracellular volume expansion (edema) plays a role in the pathophysiology of BPD. Perlman et al.'s 1986 study demonstrated that infants who died from BPD exhibited hypochloremia, metabolic alkalosis, and complications like inadequate head growth, more frequently than those who survived. These findings highlight the critical importance of chloride imbalance in neonates, similar to findings in adult and pediatric populations.
This study aims to investigate the relationship between chloride balance and two major outcomes-mortality and the development of BPD-in preterm infants. Infants <32 weeks postmentruel age (PMA) or weighing less than 1500 grams will be enrolled in the study. We also plan to explore the relationship of dyschloremia with other outcomes of prematurity (eg: patent ductus arteriosus, ventilator dependency, retinopathy of prematurity (ROP), necrotizing enterocolitis, intraventricular hemorrhage, periventricular leukomalacia, hospital stay. Lastly we plan to explore the risk factors and clinical/laboratory conditions that are associated with chloride level abnormalities.
If this study yields findings that underscore the clinical significance of chloride levels in preterm infants, similar to adults and children, then close monitoring of chloride balance and appropriate interventions could potentially reduce mortality and BPD incidence in preterm infants. Conversely, if results indicate that chloride balance lacks clinical significance in preterm infants, this will also contribute valuable information to the current literature.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Infants died before 36 weeks PMA, infants diagnosed to have BPD at 36 weeks PMA and infants developed major complications before 36 weeks PMA:
Infants discharged before 36 weeks PMA and infants who reached 36 weeks PMA without BPD and major complications:
Infants died before 36 weeks PMA and infants diagnosed to have BPD at 36 weeks PMA
Time frame: From enrollment to the end of 36 weeks PMA
BPD at 36 weeks PMA
Time frame: From enrollment to the end of 36 weeks PMA
Mortality within 36 weeks PMA
Time frame: From enrollment to the end of 36 weeks PMA
>Stage 2 necrotizing enterocolitis according to Bell classification within 36 weeks PMA
Time frame: From enrollment to the end of 36 weeks PMA
Hemodynamically significant patent ductus arteriosus within 36 weeks PMA
Time frame: From enrollment to the end of 36 weeks PMA
>Grade 2 intraventricular hemorrhage within 36 weeks PMA
Time frame: From enrollment to the end of 36 weeks PMA
Retinopathy of prematurity, ICROP classification stage >2 at 36 weeks PMA
Time frame: From enrollment to the end of 36 weeks PMA
>Stage 2 cystic periventricular leukomalacia at 36 weeks PMA
Time frame: From enrollment to the end of 36 weeks PMA
Ventricular dilatation/hydrocephalus requiring intervention at 36 weeks PMA
Contact information is provided by the study sponsor or research team.
Kanuni Sultan Suleyman Training and Research Hospital
Other
The Impact of Chloride Imbalance on BPD Development and Mortality in Preterm Infants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07109791
Antibiotic-Resistant Organisms (AROs), Bronchopulmonary Dysplasia
Edmonton, Alberta, Canada
View Trial DetailsNCT07052201
Bronchopulmonary Dysplasia, Bronchopulmonary Dysplasia (BPD)
Hangzhou, Zhejiang, China
View Trial DetailsNCT07123948
Bronchopulmonary Dysplasia, Bronchopulmonary Dysplasia (BPD)
Rijeka, Primorje-Gorski Kotar County, Croatia
View Trial DetailsNCT07058025
Bronchopulmonary Dysplasia, Bronchopulmonary Dysplasia (BPD)
Edmonton, Alberta, Canada
View Trial Details